Deep Longevity is developing explainable artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. It is also developing systems for the emerging field of longevity medicine that'll enable physicians to make better decisions on the interventions that may slow down, or reverse the aging processes.
Deep Longevity has developed a Longevity as a Service (LaaS)© solution to integrate multiple, deep biomarkers of aging dubbed “deep aging clocks” to provide a universal multifactorial measure of human biological age.
Deep Longevity started its journey in 2020 after securing a round of funding from the most credible venture capitalists specializing in biotechnology, longevity, and artificial intelligence. ETP Ventures, Human Longevity and Performance Impact Venture Fund, BOLD Capital Partners, Longevity Vision Fund, LongeVC, co-founder of Oculus, Michael Antonov, and other expert AI and biotechnology investors supported the company.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Hong Kong, Hk
- Industry
- Health And Human Services
- NAICS
-
Administration of Human Resource ProgramsAdministration of Veterans' Affairs
- Website
- deeplongevity.com
- HQ
- Hong Kong
Deep Longevity Questions
Deep Longevity's website is deeplongevity.com
Deep Longevity's LinkedIn profile is https://hk.linkedin.com/company/deeplongevity
Deep Longevity has
9 employees.
View email and phone details for 9
employees at Deep Longevity.
Deep Longevity's industry is
Health and Human Services
Deep Longevity's top competitors are
Longevity Biotech Fellowship,
Haut.ai,
Bioage Labs,
Altos Labs,
Juvenescence®,
Longevity Education Hub,
Decode Age,
Unity Biotechnology,
Insilico Medicine,
Healthylongevity.clinic.
Deep Longevity's categories are Health and Human Services
Deep Longevity's founding year is 2020
